Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Cytokinetics Inc
Updated Jul 16, 2026
Bhanji Muna has filed 4 SEC Form 4 filings across 4 companies in the last 90 days — selling. Lifetime open-market sales: $43K.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | ARDX | ARDELYX, INC. | A — Grant or award | 26.5K | $0.00 | |
| 2026-06-15 | VCYT | VERACYTE, INC. | A — Grant or award | 5.3K | $0.00 | |
| 2026-06-10 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 9.2K | $0.00 | |
| 2026-05-27 | CYTK | CYTOKINETICS INC | A — Grant or award | 2.9K | $0.00 | |
| 2025-05-15 | CYTK | CYTOKINETICS INC | S — Open-market sale | 1.5K | $29.73 | $43K |
| 2025-05-14 | CYTK | CYTOKINETICS INC | A — Grant or award | 7.3K | $0.00 |
Bhanji Muna is a corporate insider — currently tracked as Director of ARDELYX, INC. (ARDX). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 4 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($43K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bhanji Muna profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.